I think we need to completely focus on long haulers. We are getting spread to thin. I am not aware of anything approved for longhaulers at this point. As long as we meet some endpoint in the LH trial, I would think we have a chance at an EUA at least.

Spend the extra money to make sure the study is done correctly and PR'd the right way. If there is no other company to talk about (we are the only one doing long haulers) then I would think national media would start talking about us if results (again pay $$$ for a good PR team) were good.

The longhauler population has already been established and there is no real SOC at this point. They are waiting on a drug to help them resume a 'normal' life. Let's just focus on that. It will more than get us the cash to start taking our vision of oncology into a reality